Corbus Pharmaceuticals Holdings logo

Corbus Pharmaceuticals Holdings CRBP

$ 10.41 -5.36%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Yuval Cohen

Employees in the company

141

Shares

4.33 M

Market Cap[1]

$ 43.9 M

EBITDA (LTM)

$ -44.9 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.